big time gift
Houston hospital receives anonymous $50M donation to support specialty treatments
On the heels of kicking off construction for a $1.4 billion hospital tower at the Texas Medical Center, Houston Methodist has announced an anonymous $50 million gift.
The donation is the second largest received in the 102-year history of Houston Methodist.
Coupled with matching gifts and other sources of money, the gift’s overall impact will exceed $154 million, Houston Methodist says. Among the areas that will benefit from the funds are orthopedics, sports medicine, neuroprosthetics, gastrointestinal medicine, and immunology.
“Houston Methodist is honored to have the support of generous donors who entrust us to continue building on our legacy of leading medicine,” Dr. Marc Boom, president and CEO of Houston Methodist, says in a news release.
“This donor represents the giving spirit of the Houston community and believes in the unparalleled work our physicians, researchers, and staff do to bring lifesaving and life-changing treatments to our patients throughout the city and the country,” Boom adds. “We’re humbled to have this support and excited for what it will help us accomplish in the future.”
Highlights of the gift’s impact include:
- Creation of an endowed position for the Houston Methodist Neuromodulation & Recovery Laboratory in collaboration with Rice University’s George R. Brown School of Engineering.
- Support of the Center for Musculoskeletal Regeneration and Joint Preservation and Outcomes Laboratory.
- Establishment of at least 20 endowments and support of special programs in areas such as imaging, nursing, ophthalmology, reconstructive surgery, surgery, and women’s health.
Earlier this month, Houston Methodist said it started construction on the 26-story Centennial Tower at the Texas Medical Center.
Set to open in 2027, the tower will include a larger emergency department and hundreds of patient beds, among other features. The new tower will replace Houston Methodist’s Houston Main building and West Pavilion.